-
公开(公告)号:KR1020100033573A
公开(公告)日:2010-03-31
申请号:KR1020080092515
申请日:2008-09-22
Applicant: 성균관대학교산학협력단
Abstract: PURPOSE: A composition containing Chrysanthemum x morifolium extract is provided to suppress degranulation of mast cells and anaphylactic shock and relieve atopic dermatitis. CONSTITUTION: A method for producing Chrysanthemum x morifolium extract comprises: a step of mixing Chrysanthemum x morifolium and depositing; a step of extracting deposition product by an ultrasonic extractor; and a step of filtering the extract. The solvent contains 8.0 weight% of ethanol, 24.0 weight% of 1,3-butyleneglycol, and 48.0 weight% of purified water. The ultrasonic wave extraction is performed by treating at 40°C, 40kHz, and 300 Watt for one hour and treating at 50°C, 40kHz, and 500 Watt for 1 hour. A composition for preventing and treating inflammatory diseases contains 0.001-5 weight% of Chrysanthemum x morifolium extract.
Abstract translation: 目的:提供含有菊花提取物的组合物,以抑制肥大细胞的脱粒和过敏性休克,缓解特应性皮炎。 构成:生产菊花提取物的方法包括:将菊花混合并沉淀的步骤; 通过超声提取器提取沉积物的步骤; 以及过滤提取物的步骤。 溶剂含有8.0重量%的乙醇,24.0重量%的1,3-丁二醇和48.0重量%的净化水。 超声波提取通过在40℃,40kHz和300瓦处理1小时进行处理,并在50℃,40kHz和500瓦处理1小时。 用于预防和治疗炎性疾病的组合物含有0.001-5重量%的菊花提取物。